Shanxi Zhendong Pharmaceutical Co.,Ltd (300158.SZ)
300158.SZ Stock Price Chart
Explore Shanxi Zhendong Pharmaceutical Co.,Ltd interactive price chart. Choose custom timeframes to analyze 300158.SZ price movements and trends.
300158.SZ Company Profile
Discover essential business fundamentals and corporate details for Shanxi Zhendong Pharmaceutical Co.,Ltd (300158.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
7 Jan 2011
Employees
3.58K
Website
https://www.zdjt.comCEO
Lianmin Yang
Description
Shanxi Zhendong Pharmaceutical Co.,Ltd, together with its subsidiaries, researches, develops, manufactures, and markets pharmaceutical products and Chinese medicines in China. It offers cancer drugs, cardiovascular drugs, infectious disease drugs, and respiratory drugs; antibiotics, antitumor drugs, vitamins, etc.; Chinese medicines; calcium preparations; and active pharmaceutical ingredients, as well as sells gastrointestinal drugs. The company offers its products in various dosage forms, such as large volume injections, small volume injections, powder injections, lyophilized powders, tablets, hard capsules, granules, dry suspensions, ointments, psychotropic substances, and other formulations Shanxi Zhendong Pharmaceutical Co.,Ltd is based in Changzhi, China.
300158.SZ Financial Timeline
Browse a chronological timeline of Shanxi Zhendong Pharmaceutical Co.,Ltd corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 16 May 2025
EPS came in at -¥1.38 , while revenue for the quarter reached ¥701.70M .
Earnings released on 31 Mar 2025
EPS came in at ¥0.00 , while revenue for the quarter reached ¥754.53M .
Earnings released on 29 Sept 2024
EPS came in at ¥0.01 , while revenue for the quarter reached ¥762.82M .
Earnings released on 30 Jun 2024
EPS came in at ¥0.01 , while revenue for the quarter reached ¥724.47M .
Earnings released on 17 May 2024
EPS came in at -¥0.04 , while revenue for the quarter reached ¥842.27M .
Earnings released on 31 Mar 2024
EPS came in at ¥0.02 , while revenue for the quarter reached ¥782.13M .
Earnings released on 30 Sept 2023
EPS came in at -¥0.02 , while revenue for the quarter reached ¥850.86M .
Earnings released on 30 Jun 2023
EPS came in at ¥0.01 , while revenue for the quarter reached ¥981.47M .
Earnings released on 31 Mar 2023
EPS came in at -¥0.00 , while revenue for the quarter reached ¥951.42M .
Earnings released on 1 Jan 2023
EPS came in at -¥0.07 , while revenue for the quarter reached ¥929.39M .
Earnings released on 30 Sept 2022
EPS came in at ¥0.00 , while revenue for the quarter reached ¥1.07B .
Earnings released on 30 Jun 2022
EPS came in at ¥0.02 , while revenue for the quarter reached ¥836.80M .
Dividend declared on 9 May 2022
A dividend of ¥2.70 per share was announced, adjusted to ¥2.70. The dividend was paid on 9 May 2022.
Earnings released on 31 Mar 2022
EPS came in at ¥0.01 , while revenue for the quarter reached ¥888.84M .
Earnings released on 31 Dec 2021
EPS came in at ¥2.23 , while revenue for the quarter reached ¥1.04B .
Earnings released on 30 Sept 2021
EPS came in at ¥0.10 , while revenue for the quarter reached ¥1.41B .
Dividend declared on 13 Sept 2021
A dividend of ¥0.10 per share was announced, adjusted to ¥0.10. The dividend was paid on 13 Sept 2021.
Earnings released on 30 Jun 2021
EPS came in at ¥0.12 , while revenue for the quarter reached ¥1.35B .
Dividend declared on 26 May 2021
A dividend of ¥0.07 per share was announced, adjusted to ¥0.07. The dividend was paid on 26 May 2021.
Earnings released on 27 Apr 2021
EPS came in at ¥0.05 , while revenue for the quarter reached ¥1.48B .
Earnings released on 31 Mar 2021
EPS came in at ¥0.10 , while revenue for the quarter reached ¥1.29B .
Earnings released on 30 Sept 2020
EPS came in at ¥0.09 , while revenue for the quarter reached ¥1.40B .
300158.SZ Stock Performance
Access detailed 300158.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.